- Home
- IVVD vs MDAI Comparison
IVVD vs MDAI Comparison
Compare IVVD & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- MDAI
- Stock Information
- Founded
- IVVD 2020
- MDAI 2013
- Country
- IVVD United States
- MDAI United States
- Employees
- IVVD N/A
- MDAI N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- MDAI Medical/Dental Instruments
- Sector
- IVVD Health Care
- MDAI Health Care
- Exchange
- IVVD Nasdaq
- MDAI Nasdaq
- Market Cap
- IVVD 63.4M
- MDAI 51.9M
- IPO Year
- IVVD 2021
- MDAI N/A
- Fundamental
- Price
- IVVD $1.60
- MDAI $2.38
- Analyst Decision
- IVVD Strong Buy
- MDAI Strong Buy
- Analyst Count
- IVVD 5
- MDAI 1
- Target Price
- IVVD $5.11
- MDAI $3.50
- AVG Volume (30 Days)
- IVVD 4.4M
- MDAI 529.7K
- Earning Date
- IVVD 11-13-2025
- MDAI 11-05-2025
- Dividend Yield
- IVVD N/A
- MDAI N/A
- EPS Growth
- IVVD N/A
- MDAI N/A
- EPS
- IVVD N/A
- MDAI N/A
- Revenue
- IVVD $46,210,000.00
- MDAI $27,549,000.00
- Revenue This Year
- IVVD $112.35
- MDAI N/A
- Revenue Next Year
- IVVD $272.14
- MDAI $60.05
- P/E Ratio
- IVVD N/A
- MDAI N/A
- Revenue Growth
- IVVD 1941.08
- MDAI 22.27
- 52 Week Low
- IVVD $0.35
- MDAI $1.01
- 52 Week High
- IVVD $2.74
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- IVVD 71.86
- MDAI 58.65
- Support Level
- IVVD $1.15
- MDAI $2.21
- Resistance Level
- IVVD $1.15
- MDAI $2.49
- Average True Range (ATR)
- IVVD 0.12
- MDAI 0.16
- MACD
- IVVD 0.02
- MDAI 0.03
- Stochastic Oscillator
- IVVD 99.85
- MDAI 73.06
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.